本页面由Tiger Trade Technology Pte. Ltd.提供服务

1药网

7.40
-0.3200-4.15%
成交量:1.08万
成交额:8.12万
市值:6,413.90万
市盈率:-6.52
高:7.61
开:7.55
低:7.40
收:7.72
52周最高:11.35
52周最低:2.48
股本:866.74万
流通股本:350.51万
量比:1.26
换手率:0.31%
股息:- -
股息率:- -
每股收益(TTM):-1.1341
每股收益(LYR):-1.0324
净资产收益率:-10.86%
总资产收益率:-0.21%
市净率:-0.65
市盈率(LYR):-7.17

数据加载中...

2025/08/29

SEC问询函

Form CORRESP - Correspondence
2025/08/29

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/08/22

SEC问询函

Form CORRESP - Correspondence
2025/08/06

SEC问询函

Form CORRESP - Correspondence
2025/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/14

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/02

SEC问询函

Form CORRESP - Correspondence
2023/07/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/31

SEC问询函

CORRESP [Cover] - Correspondence
2022/10/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/27

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/23

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/19

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]